An Open-Label, Phase 1B Study of NEO-PV-01 With Pembrolizumab Plus Chemotherapy in Patients With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 29 Dec 2017
At a glance
- Drugs NEO-PV 01 (Primary) ; Pembrolizumab (Primary) ; Carboplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Sponsors Neon Therapeutics
- 19 Dec 2017 Status changed from planning to not yet recruiting.
- 12 Dec 2017 New trial record
- 07 Dec 2017 According to a Neon Therapeutics media release, neon therapeutics will collaborate with merck to conduct this phase Ib trial.